Insider · CIK 0001909592
Aleksandar Rajkovic
Files at BNGO (Bionano Genomics, Inc.). First filing -, latest -.
In brief
Aleksandar Rajkovic files SEC Form 4 as director at BNGO (Bionano Genomics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Aleksandar Rajkovic has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 14, 2026 | BNGO Bionano Genomics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +9,149 | $0.00 | $0 | 9,149 | May 14, 2026 |
| Jun 11, 2025 | BNGO Bionano Genomics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +2,775 | $0.00 | $0 | 2,775 | Jun 12, 2025 |
| Jun 18, 2024 | BNGO Bionano Genomics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 20, 2024 |
Questions about Aleksandar Rajkovic
Answered from the filings on this page, as of the latest one.
Is Aleksandar Rajkovic buying or selling?
Aleksandar Rajkovic has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Aleksandar Rajkovic's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Aleksandar Rajkovic has 0.
Where does Aleksandar Rajkovic file Form 4?
Aleksandar Rajkovic has filed Form 4 at BNGO (Bionano Genomics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.